Wegovy (semaglutide injection, for weight loss): Approximately $1,350 per month
In August 2025, Eli Lilly (US) announced a collaboration with a leading technology firm to integrate artificial intelligence into its drug development processes
Chronic co-administration of bezafibrate with the GLP-1 analogue exendin-4, but not with the GIP receptor (GIPR) agonist [d-Ala 2 ]GIP(130) (D-GIP), enhanced the glucose-lowering effect of exendin-4 in db/db mice, and this was associated with improved islet morphology and increased beta cell mass and proliferation
Commercial patch safety concerns Without clinical trials or regulatory oversight, the safety profile of commercial patches is largely unknown: Ingredient quality : No verification of purity or potency Skin reactions : Adhesives and ingredients may cause irritation or allergic responses Interactions : Herbal components like berberine may interact with medications Undisclosed ingredients : Some patches may contain undeclared substances The MHRA doesnt evaluate these products before they reach the market, and adverse events arent systematically collected or reviewed
mercer.com 8AAOPM (April 2026)
The margin of error for the full sample is approximately 3 percentage points at the 95% confidence level.
